News for ImmuCell Corporation (ICCC)

ICCC posts record Q1 sales, returns to earnings and expands margins y/y as First Defense demand grows and production issues subside.

ImmuCell Corporation (ICCC) to report Q1 2025 unaudited financial results on May 14, 2025. Conference call scheduled for May 15, 2025, at 9:00 AM ET to

Conference Call Scheduled for Thursday, May 15, 2025 at 9:00 AM ET PORTLAND, Maine, May 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation ( ICCC) (”œImmuCe

**media[587932]**

PORTLAND, Maine, April 02, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation ( ICCC) (”œImmuCell” or the ”œCompany”), a growing animal health company that d

ImmuCell posts 52% y/y sales growth in Q4. It improves margins and eyes FDA approval for Re-Tain to drive expansion.

ImmuCell Corporation (NASDAQ:ICCC) Q4 2024 Earnings Conference Call February 26, 2025 9:00 AM ETCompany ParticipantsJoe Diaz - Managing Partner, Lytham...

PORTLAND, Maine, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation ( ICCC) (”œImmuCell” or the ”œCompany”), a growing animal health company that de

Apple, Eli Lilly, Shopify and ImmuCell are part of the Zacks top Analyst Blog.

**media[517339]**

ImmuCell Corporation reports preliminary sales of $7.8M in Q4 and expects FY 2024 sales of $26.5M, driven by strong demand from distributors.

**media[511167]**

Discover why Zacks, being the first on Wall Street to initiate the stock coverage, rates ImmuCell as

Nov 14, 2024 / 02:00PM GMTOperator Good morning and welcome to ImmuCell Corporation reports third quarter September 30, 2024, unaudited financial results confer

ICCC sees strong Q3 sales growth but faces challenges with margins. It awaits FDA approval for its groundbreaking Re-Tain product.

ImmuCell Corporation (NASDAQ:ICCC) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ETCompany ParticipantsJoe Diaz - Lytham PartnersMichael...

**media[431845]**

Aug 14, 2024 / 01:00PM GMTOperator Good morning, and welcome to the ImmuCell Corporation Reports second quarter ended June 30, 2024, unaudited financial results

ImmuCell Corporation (NASDAQ:NASDAQ:ICCC) Q2 2024 Earnings Conference Call August 14, 2024 9:00 AM ETCompany ParticipantsJoe Diaz - Lytham PartnersMichael...